Foley & Lardner LLP represented TCG Crossover on the deal while Dechert advised Abivax.TCG Crossover (TCGX) acted as the lead investor in the successful, oversubscribed EUR 49.2…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
